Osteopenia Completed Phase 4 Trials for Alfacalcidol (DB01436)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00168909Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)Treatment